| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |